vs
Side-by-side financial comparison of Finwise Bancorp (FINW) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $46.9M, roughly 1.8× Finwise Bancorp). Finwise Bancorp runs the higher net margin — 8.4% vs -38.1%, a 46.4% gap on every dollar of revenue. On growth, Finwise Bancorp posted the faster year-over-year revenue change (121.7% vs 20.2%). Over the past eight quarters, Finwise Bancorp's revenue compounded faster (54.3% CAGR vs 24.8%).
Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
FINW vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $46.9M | $83.1M |
| Net Profit | $3.9M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 11.7% | -4.1% |
| Net Margin | 8.4% | -38.1% |
| Revenue YoY | 121.7% | 20.2% |
| Net Profit YoY | 40.1% | -27.9% |
| EPS (diluted) | $0.27 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $46.9M | $76.4M | ||
| Q3 25 | $36.7M | $83.3M | ||
| Q2 25 | $25.1M | $79.2M | ||
| Q1 25 | $22.1M | $69.2M | ||
| Q4 24 | $21.1M | $68.2M | ||
| Q3 24 | $20.8M | $58.4M | ||
| Q2 24 | $19.8M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $3.9M | $-29.8M | ||
| Q3 25 | $4.9M | $-21.4M | ||
| Q2 25 | $4.1M | $-19.6M | ||
| Q1 25 | $3.2M | $-24.7M | ||
| Q4 24 | $2.8M | $-18.9M | ||
| Q3 24 | $3.5M | $-21.0M | ||
| Q2 24 | $3.2M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 11.7% | -40.6% | ||
| Q3 25 | 17.5% | -27.8% | ||
| Q2 25 | 21.7% | -28.0% | ||
| Q1 25 | 20.1% | -39.7% | ||
| Q4 24 | 17.5% | -28.9% | ||
| Q3 24 | 22.2% | -38.4% | ||
| Q2 24 | 21.1% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 8.4% | -39.1% | ||
| Q3 25 | 13.3% | -25.7% | ||
| Q2 25 | 16.3% | -24.7% | ||
| Q1 25 | 14.4% | -35.8% | ||
| Q4 24 | 13.2% | -27.6% | ||
| Q3 24 | 16.6% | -35.9% | ||
| Q2 24 | 16.1% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.27 | $-0.54 | ||
| Q3 25 | $0.34 | $-0.38 | ||
| Q2 25 | $0.29 | $-0.35 | ||
| Q1 25 | $0.23 | $-0.45 | ||
| Q4 24 | $0.19 | $-0.34 | ||
| Q3 24 | $0.25 | $-0.40 | ||
| Q2 24 | $0.24 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $163.4M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $193.2M | $347.7M |
| Total Assets | $977.1M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $163.4M | $286.5M | ||
| Q3 25 | $105.6M | $294.3M | ||
| Q2 25 | $90.1M | $302.7M | ||
| Q1 25 | $120.3M | $316.2M | ||
| Q4 24 | $109.2M | $333.7M | ||
| Q3 24 | $85.8M | $196.8M | ||
| Q2 24 | $89.0M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $193.2M | $365.9M | ||
| Q3 25 | $187.8M | $380.3M | ||
| Q2 25 | $182.0M | $385.8M | ||
| Q1 25 | $177.4M | $389.2M | ||
| Q4 24 | $173.7M | $402.2M | ||
| Q3 24 | $170.4M | $241.2M | ||
| Q2 24 | $165.8M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $977.1M | $508.1M | ||
| Q3 25 | $899.9M | $511.5M | ||
| Q2 25 | $842.5M | $513.1M | ||
| Q1 25 | $804.1M | $519.4M | ||
| Q4 24 | $746.0M | $534.0M | ||
| Q3 24 | $683.0M | $374.1M | ||
| Q2 24 | $617.8M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-28.4M | — |
| Free Cash FlowOCF − Capex | $-28.6M | — |
| FCF MarginFCF / Revenue | -61.1% | — |
| Capex IntensityCapex / Revenue | 0.5% | — |
| Cash ConversionOCF / Net Profit | -7.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-68.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-28.4M | $-10.3M | ||
| Q3 25 | $3.5M | $-6.6M | ||
| Q2 25 | $-18.3M | $-15.0M | ||
| Q1 25 | $-21.6M | $-17.0M | ||
| Q4 24 | $-15.0M | $-32.4M | ||
| Q3 24 | $-9.8M | $-18.8M | ||
| Q2 24 | $-7.6M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $-12.2M | ||
| Q3 25 | $3.4M | $-9.5M | ||
| Q2 25 | $-19.8M | $-17.8M | ||
| Q1 25 | $-23.3M | $-18.8M | ||
| Q4 24 | $-16.1M | $-33.6M | ||
| Q3 24 | $-13.4M | $-19.0M | ||
| Q2 24 | $-7.7M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | -61.1% | -15.9% | ||
| Q3 25 | 9.4% | -11.4% | ||
| Q2 25 | -79.0% | -22.5% | ||
| Q1 25 | -105.3% | -27.2% | ||
| Q4 24 | -76.0% | -49.2% | ||
| Q3 24 | -64.3% | -32.6% | ||
| Q2 24 | -38.7% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 2.4% | ||
| Q3 25 | 0.1% | 3.4% | ||
| Q2 25 | 5.8% | 3.5% | ||
| Q1 25 | 7.4% | 2.7% | ||
| Q4 24 | 5.1% | 1.7% | ||
| Q3 24 | 17.2% | 0.4% | ||
| Q2 24 | 0.3% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | -7.26× | — | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | -4.48× | — | ||
| Q1 25 | -6.78× | — | ||
| Q4 24 | -5.37× | — | ||
| Q3 24 | -2.84× | — | ||
| Q2 24 | -2.39× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FINW
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
